8-K/A
filed October 9, 2024, 7:59 PM ET
ticker BRGX
CIK 0001593184
M&A
confidence high
sentiment negative
materiality 0.75
BioRegenx completes reverse merger; posts $3.6M net loss in 2023 with going concern doubt
BIOREGENX, INC.
- Merger effective March 8, 2024: BioRegenx merged into Findit; registrant renamed BioRegenx, Inc.
- Exchanged 851.98M shares and 3,800 Series A preferred for 90% voting control; retired prior preferred and 172.2M common shares.
- Audited 2023 results: net loss $3.6M, sales $3.41M, stockholders' deficit $2.07M; auditor flags going concern.
- New leadership: William Resides CEO/Interim CFO; new board of 7 directors appointed (8 total including Thomas Powers).
- Authorized common increased to 1.5B shares; Series A preferred voting rights corrected to 2,500 votes per share.
Key facts
Extracted from this filing and checked against the source text.
Executive change
SEC 8-K Item 5.02
confidence 0.95
Gary Hennerberg was appointed as Director at BIOREGENX, INC..
- Action
- appointed
- Role
- Director
Exact text from the filing
the following directors were appointed to join Thomas Powers on the Board of Directors: William Resides Robert Doran Sherri Adams Gary Hennerberg Suzanne Bird Jody Walker Gary Kiss
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Gary Hennerberg was appointed as Secretary at BIOREGENX, INC..
- Action
- appointed
- Role
- Secretary
Exact text from the filing
Gary Hennerberg – Secretary
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Jody Walker was appointed as Director at BIOREGENX, INC..
- Action
- appointed
- Role
- Director
Exact text from the filing
the following directors were appointed to join Thomas Powers on the Board of Directors: William Resides Robert Doran Sherri Adams Gary Hennerberg Suzanne Bird Jody Walker Gary Kiss
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Robert Doran was appointed as Executive Vice President at BIOREGENX, INC..
- Action
- appointed
- Role
- Executive Vice President
Exact text from the filing
Robert Doran – Executive Vice President
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Sherri Adams was appointed as Director at BIOREGENX, INC..
- Action
- appointed
- Role
- Director
Exact text from the filing
the following directors were appointed to join Thomas Powers on the Board of Directors: William Resides Robert Doran Sherri Adams Gary Hennerberg Suzanne Bird Jody Walker Gary Kiss
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Sherri Adams was appointed as Chief Operating Officer at BIOREGENX, INC..
- Action
- appointed
- Role
- Chief Operating Officer
Exact text from the filing
Sherri Adams – Chief Operating Officer
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Robert Doran was appointed as Director at BIOREGENX, INC..
- Action
- appointed
- Role
- Director
Exact text from the filing
the following directors were appointed to join Thomas Powers on the Board of Directors: William Resides Robert Doran Sherri Adams Gary Hennerberg Suzanne Bird Jody Walker Gary Kiss
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Thomas Powers resigned as other_named_officer at BIOREGENX, INC..
- Action
- resigned
Exact text from the filing
Effective March 8, 2024, Raymond Firth and Thomas Powers resigned as officers of the Registrant
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
William Resides was appointed as Interim Financial Officer at BIOREGENX, INC..
- Action
- appointed
- Role
- Interim Financial Officer
Exact text from the filing
William Resides – Chief Executive Officer, Interim Financial Officer
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Suzanne Bird was appointed as Director at BIOREGENX, INC..
- Action
- appointed
- Role
- Director
Exact text from the filing
the following directors were appointed to join Thomas Powers on the Board of Directors: William Resides Robert Doran Sherri Adams Gary Hennerberg Suzanne Bird Jody Walker Gary Kiss
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Raymond Firth resigned as other_named_officer at BIOREGENX, INC..
- Action
- resigned
Exact text from the filing
Effective March 8, 2024, Raymond Firth and Thomas Powers resigned as officers of the Registrant
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
William Resides was appointed as Director at BIOREGENX, INC..
- Action
- appointed
- Role
- Director
Exact text from the filing
the following directors were appointed to join Thomas Powers on the Board of Directors: William Resides Robert Doran Sherri Adams Gary Hennerberg Suzanne Bird Jody Walker Gary Kiss
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
William Resides was appointed as Chief Executive Officer at BIOREGENX, INC..
- Action
- appointed
- Role
- Chief Executive Officer
Exact text from the filing
William Resides – Chief Executive Officer, Interim Financial Officer
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Raymond Firth resigned as director at BIOREGENX, INC..
- Action
- resigned
Exact text from the filing
Effective March 8, 2024, Raymond Firth resigned as a director of the Registrant
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Gary Kiss was appointed as Director at BIOREGENX, INC..
- Action
- appointed
- Role
- Director
Exact text from the filing
the following directors were appointed to join Thomas Powers on the Board of Directors: William Resides Robert Doran Sherri Adams Gary Hennerberg Suzanne Bird Jody Walker Gary Kiss
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.